Editorial: Driving Change in the Pharma Industry and Biotech One Relationship at a Time

PharmasAlmanac_Q1_2018.pngAs published in Pharma's Almanac Q1 2018.

Although small and medium-sized pharma and biotech companies are driving the growth of the industry, they often don’t receive the attention and assistance that are essential to their success. Changing the industry’s mindset is critical. Alcami is establishing many different relationships intended to facilitate and accelerate just that.

Historically, growth in the pharmaceutical industry has been driven by large pharmaceutical companies developing blockbuster drugs. That is no longer the case. Many companies today are focused on the development of treatments for diseases that afflict much smaller patient populations. A majority of these firms are founded by academic researchers that have discovered new molecules with desirable biological activities. Indeed, the success rates of smaller firms are often higher; the Tufts Center for the Study of Drug Development reports that smaller firms developing small-molecule drugs have higher clinical approval success rates than large companies.¹

Read Full Article Here

Topics: Thought Leadership Editorials